Melanoma-Derived Growth Regulatory Protein (MIA) Antibody (FITC)

Este producto es parte de MIA - MIA SH3 domain containing
Melanoma-Derived Growth Regulatory Protein (MIA) Antibody (FITC)
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Melanoma-Derived Growth Regulatory Protein (MIA) Antibody (FITC)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx336487

Description

MIA Antibody (FITC) is a Rabbit Polyclonal against MIA.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Melanoma-Derived Growth Regulatory Protein (MIA)
Immunogen: Recombinant Human Melanoma-derived growth regulatory protein (87-124AA).
Host
Rabbit
Reactivity
Human
Detection Method
Laser Line: 488
Excitation/Emission: 499/515
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q16674
Gene ID
8190
Alias
Melanoma inhibitory activity protein,MIA1,CD-RAP
Background
Antibody anti-MIA
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

MIA, also known as Melanoma Inhibitory Activity, is a small secreted protein primarily expressed in melanocytes and chondrocytes, where it regulates cell adhesion, migration, and tumor progression It acts by disrupting the interaction between integrins and the extracellular matrix, facilitating detachment and migration of tumor cells MIA is highly expressed in malignant melanoma and is used as a biomarker for disease progression, metastasis, and treatment monitoring Elevated MIA levels are also observed in other cancers, such as chondrosarcoma and hepatocellular carcinoma, where it contributes to tumor invasiveness Its role extends to cartilage homeostasis and chondrocyte differentiation, implicating MIA in cartilage-related disorders like osteoarthritis Targeting MIA holds therapeutic potential in inhibiting tumor cell dissemination and cartilage degeneration

Productos relacionados

abx014575

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody

Rabbit polyclonal antibody against MIA protein. Immunogen region is C-terminal.…

Ver producto
abx130313

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody

Melanoma Inhibitory Activity Protein 1 Antibody is a Rabbit Polyclonal against Melanoma Inhibitory Activity Protein 1.…

Ver producto
abx130858

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody is a Rabbit Polyclonal against Melanoma-Derived Growth Regulat…

Ver producto